Tech Series: AI-Driven Cancer Detection & The Future of Preventive Imaging with Emi Gal, CEO of Ezra

Host Jason Schifman sits down with Emi Gal, CEO and founder of Ezra, a company pioneering AI-powered full-body MRI scans for early cancer detection. Emi shares his personal motivation behind founding Ezra, how AI-driven imaging innovations are reshaping preventive medicine, and why his company is expanding access to affordable cancer screening.

The discussion explores healthcare industry insights around medical imaging, healthcare innovations, and the role of AI in streamlining cancer detection. Emi also shares the challenges of building strategic partnerships with imaging centers, scaling direct-to-consumer healthcare, and addressing false positives in full-body MRI scans.

Timestamps:

• [00:00] Introduction to the podcast and guest, Emi Gal, CEO of Ezra
• [02:00] How personal experience led Emi to launch Ezra & revolutionize early cancer detection
• [06:30] The Ezra model: Direct-to-consumer AI-powered full-body MRIs
• [12:00] Partnering with imaging centers: How Ezra operates without owning facilities
• [18:00] AI’s role in making MRIs faster, more efficient, and more affordable
• [24:30] Scaling a direct-to-consumer health tech business: Challenges & successes
• [30:00] Addressing concerns over false positives, incidental findings, and patient anxiety
• [40:00] The future of AI-driven preventive imaging and healthcare innovation
• [50:00] What’s next for Ezra: Expanding affordability, increasing access, and AI advancements

Key Takeaways:

• AI-driven medical imaging is revolutionizing preventive healthcare. Ezra’s full-body MRI scans use AI to enhance speed, accuracy, and affordability, making early cancer detection more accessible.
• Strategic partnerships with imaging centers fuel Ezra’s rapid expansion. Rather than building facilities, Ezra leverages excess capacity in existing imaging centers, driving operational efficiency and scalability.
• False positives and incidental findings are a key challenge—but AI helps mitigate them. Ezra scores findings on a scale of 1-5, ensuring that only high-risk cases trigger follow-ups, reducing unnecessary procedures.
• Ezra’s long-term vision is a $600 AI-powered 15-minute scan. By continuing AI innovation, the goal is to make full-body cancer screening widely available, insurance-covered, and a standard preventive measure.

Resources:

Ezra Website

LinkedIn

Twitter/X

About the Guest:

Emi Gal is the founder and CEO of Ezra, an AI company pioneering the use of full-body MRI to detect cancer as early as possible. He is a software engineer and entrepreneur passionate about healthcare and longevity. Emi started his first company, Brainient, during his first year at university and spent the following 10 years building it into one of the leading ad-tech companies in Europe. Brainient (now called Teads Studio) was acquired by Teads in September 2016.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, AI in Healthcare, Medical Imaging, Cancer Screening, Preventive Medicine, Health Tech